- 产品详情
- 产品参数
- 产品评论
Stemcell 73472 TG101348
Product Overview
TG101348 is an inhibitor of Janus kinase 2 (JAK2) with an IC₅₀ of 6 nM. It also inhibits related kinases fms-related tyrosine kinase 3 (FLT3), RET, and JAK3 with less potent activity, having IC₅₀ values of 25, 17 and 169 nM, respectively (Pardanani et al.). It is proposed to bind to the ATP binding pocket of its kinase targets (Zhou et al.).
CANCER RESEARCH
· Inhibits growth of Ba/F3 cells expressing JAK2 V617F or MPL W515L mutations (Pardanani et al.).
· Reduces tumor cell burden and increases survival in mouse models of JAK2 V617F-induced hematopoietic and myeloproliferative disease (Pardanani et al.; Wernig et al.).
· Sensitizes erlotinib-resistant non-small cell lung cancer cells to erlotinib treatment in vitro and in a mouse xenograft model (Zhang et al.).
· Displaces BRD4 from chromatin and suppresses c-MYC expression in multiple myeloma cells in vitro (Ciceri et al.).
CAS Number:936091-26-8
Alternative Names:Fedratinib, SAR302503
Chemical Formula:C₂₇H₃₆N₆O₃S
Molecular Weight:524.7 g/mol
Purity:≥ 98%
Pathway:JAK/STAT
Target:JAK2
Related products
Description | Catalog # | Format |
Tranylcypromine (HCl), 50 mg | 72274 | 50 mg |
Tranylcypromine (HCl), 10 mg | 72272 | 10 mg |
Trametinib, 10 mg | 73504 | 10 mg |
Trametinib, 1 mg | 73502 | 1 mg |
Torin 1, 50 mg | 73494 | 50 mg |
Torin 1, 10 mg | 73492 | 10 mg |
Tivantinib, 10 mg | 73484 | 10 mg |
Tivantinib, 1 mg | 73482 | 1 mg |
Tissue Dissociation Flask | 27300 | 1 EA |
Thiazovivin, 5 mg | 72254 | 5 mg |
Thiazovivin, 1 mg | 72252 | 1 mg |
TG101348, 10 mg | 73474 | 10 mg |
TG101348, 1 mg | 73472 | 1 mg |
Uante,您的科研物资战略合作伙伴！
重庆市寰宇安泰生物科技有限公司